16 Mar 2012
A King's College London study has found drugs that cost only 50p a day
could help 450,000 advanced sufferers of dementia in the UK. The two
drugs, Donepezil, more commonly known as Aricept, and Memantine ...
certain point because the drugs are thought to stop adding any benefit.
However, it is now claimed ...
15 May 2012
| by Hannah Crown and John Owens
Troubled drugs giant AstraZeneca has named two agencies as its preferred suppliers, amid a backdrop...The UK s second largest drug manufacturer is understood to have called in Tonic Life and Red Door Communications for its first UK list, following a seven-month procurement process.
However, industry insiders ...
is grappling with rising drug development costs, suffered a 19 per cent fall in profits in the period from ...
26 Jan 2012
| by Flo Heiss, executive creative director, Dare
this idea from McCann Digital Israel for the Israel Anti-Drug Authority. It might be a fairly obvious idea....
ROLL THE CREDITS Title: Drugs set your Timeline Client: Israel Anti-Drug Authority Brief: Use Facebook's new Timeline feature to show clean vs drug-addicted life Agency: McCann Digital Israel ...
04 May 2012
| by Ben Hall
An ad in which kids say no to 'crack' and 'meth' in place of roller skating, has entered the viral chart in third place this week with more than 40,000 shares across social networking sites and the blogosphere.
13 Mar 2012
| by Sara Luker
the need to speed up access to new drugs for blood cancer sufferers....to new drugs.
Emma Whelan, director of marketing at Leukaemia Lymphoma Research, said: MHP ...
in the process of accessing drugs.
The account will be led by MHP Health Mandate director Rachel Rowson ...
15 May 2012
| by Jane Bainbridge
an operating loss (2010 2011). OTC stakes fell but machine turnover grew in 2011 ...
08 Feb 2012
| by Jane Bainbridge
Pfizer two years ago and has held several brand management positions across healthcare, OTC and FMCG ...
01 May 2012
-driven consumer work. Heaven.
Novartis - which took us into OTC healthcare for the first time.
Simply ...
and healthcare/OTC capabilities. Push our boundaries and deliver industry-leading solutions to Marcomms ...
13 Apr 2012
| by Matt Cartmell
a 1 a day drug to delay progression of the disease and reduce the need for hip and knee replacements.
The drug, Strontium Ranelate, marketed as Protelos, is already used for people ...
07 Feb 2012
| by Elizabeth Pears
such as AstraZeneca the UK s second-biggest drug maker which announced a worldwide jobs cut of 7,300 last week ...
s position as an international competitor in creating life-changing drugs. Currently, ABPI s members supply ...
to remove filters
